On 8 June 2015
Shasun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 June 2015 to consider conversion of 71,00,000 convertible warrants into equity shares of the Company issued to M/s. Sequent Scientific Limited, Mumbai on preferential basis.Powered by Capital Market - Live News